Document:

First Amendment to the Credit Agreement

 Exhibit 10.1 

EXECUTION VERSION 

FIRST AMENDMENT dated as of August 18, 2010 (this “Amendment”), to the CREDIT AGREEMENT dated as
of February 8, 2010 (the “Credit Agreement”), among EXPEDIA, INC., a Delaware corporation; EXPEDIA, INC., a Washington corporation; TRAVELSCAPE, LLC, a Nevada limited liability company; TRIPADVISOR LLC, a Delaware limited
liability company; HOTWIRE, INC., a Delaware corporation; the other Borrowing Subsidiaries from time to time party thereto; the LENDERS from time to time party thereto; JPMORGAN CHASE BANK, N.A., as Administrative Agent; and J.P. MORGAN EUROPE
LIMITED, as London Agent. 
 WHEREAS the Lenders have agreed to extend credit to the Borrowers under the Credit Agreement on the
terms and subject to the conditions set forth therein; 
 WHEREAS the Company has requested that the Lenders (a) extend the
maturity of their Loans and the expiration of their Commitments and (b) effect certain other amendments to the Credit Agreement as set forth herein; 

WHEREAS the Lenders whose signatures appear below, constituting all the Lenders, are willing to amend the Credit Agreement on the terms
and subject to the conditions set forth herein; 
 NOW, THEREFORE, in consideration of the mutual agreements herein contained
and other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the parties hereto hereby agree as follows: 

SECTION 1. Defined Terms. Capitalized terms used but not otherwise defined herein (including in the preamble hereto) have the
meanings assigned to them in the Credit Agreement. 
 SECTION 2. Amendment of Credit Agreement. Effective as of the
Amendment Effective Date (as defined below), the Credit Agreement is hereby amended as follows: 
 (a) Amendments to
Section 1.01. Section 1.01 of the Credit Agreement is amended as follows: 
 (i) The following new
defined terms are added in appropriate alphabetical order: 
 “First Amendment” means the First
Amendment dated as of August 18, 2010, to this Agreement. 
 “First Amendment Effective
Date” means the “Amendment Effective Date” as defined in the First Amendment. 

 (ii) The definition of the term “Applicable Rate” is hereby
amended by replacing the pricing grid therein with the pricing grid below: 
  

											
	 Level
	  	Level 1	  	Level 2	  	Level 3	  	Level 4	  	Level 5
	 Rating
	  	At Least
BBB+ by
S&P/Baa1
Moody’s
	  	BBB by
S&P/Baa2 by
Moody’s
	  	BBB- by
S&P/Baa3 by
Moody’s
	  	BB+ by
S&P/Ba1 by
Moody’s
	  	Lower than
BB+ by
S&P/Ba1 by
Moody’s or
unrated
	 Commitment Fee Rate
	  	20.0	  	30.0	  	37.5	  	50.0	  	62.5
	 Eurocurrency Spread
	  	200.0	  	225.0	  	250.0	  	275.0	  	300.0
	 ABR Spread
	  	100.0	  	125.0	  	150.0	  	175.0	  	200.0

 (iii)
The definition of the term “Material Indebtedness” is hereby amended by replacing the number “US$30,000,000” therein with the number “US$50,000,000”. 

(iv) The definition of the term “Maturity Date” is hereby amended and restated in its entirety to read as
follows: 
 “Maturity Date” means the fourth anniversary of the First Amendment Effective Date.

 (v) The definition of the term “Permitted Investments” is hereby amended and restated to read in its
entirety as follows: 
 “Permitted Investments” means: 

(a) direct obligations of the United States of America (including U.S. Treasury bills, notes and bonds) that are backed by
the full faith and credit of the United States of America; 
 (b) direct obligations of any agency of the United
States of America that are backed by the full faith and credit of the United States of America; 
 (c) direct
obligations of, and obligations fully guaranteed by, any State of the United States of America that are rated investment grade by Moody’s or by S&P, including general obligation and revenue notes and bonds, insured bonds (including all
insured bonds having, at such date of acquisition, a credit rating of Aaa by Moody’s and AAA by S&P) and refunded bonds (reissued bonds collateralized by U.S. Treasury securities); 

 

 2 

 (d) Indebtedness of any county or other local governmental body within the
United States of America having, at such date of acquisition, a credit rating of Aaa by Moody’s and AAA by S&P, or Auction Rate Securities, Tax-Exempt Commercial Paper or Variable Rate Demand Notes issued by such bodies that is, on the date
of such acquisition, rated at least A3/P-1/VMIG-1 by Moody’s and A-/A-1/SP-1 by S&P; 
 (e) non-US
Dollar denominated indebtedness of other sovereign countries having, at such date of acquisition, a credit rating of Aaa by Moody’s and AAA by S&P; 

(f) non-US Dollar denominated indebtedness of government agencies having, at such date of acquisition, a credit rating of
Aaa by Moody’s and AAA by S&P; 
 (g) mortgage-backed securities of the United States of America and/or
any agency thereof that are backed by the full faith and credit of the United States of America; provided that such mortgage-backed securities that are purchased on a TBA (“To-Be-Announced”) basis must have a settlement date of less than
three months from date of purchase; 
 (h) collateralized mortgage obligations of the United States of America
and/or any agency thereof that are backed by the full faith and credit of the United States of America; 
 (i)
commercial paper issued by any corporation or bank having a maturity of nine months or less and having, at such date of acquisition, a credit rating of at least P1 or the equivalent thereof from Moody’s and A1 or the equivalent thereof from
S&P; 
 (j) money market investments, bankers acceptances, certificates of deposit, notes or time deposits
issued by any domestic bank that has a combined capital and surplus and undivided profits of not less than US$500,000,000; 

(k) money market investments, deposits, bankers acceptances, certificates of deposit and other like instruments, in each
case directly guaranteed by any commercial bank organized under the laws of a member nation of the European Union or the OECD which has a combined capital and surplus and undivided profits of not less than US$500,000,000, denominated in US Dollars,
Sterling, Euro, Canadian Dollars, Australian Dollars, Norwegian Kroner or Swiss Francs; 
 (l) direct obligations
of corporations, banks or financial entities and agencies, including medium term notes (MTN) and bonds, structured notes and Eurodollar/Yankee notes and bonds, in each case having, at the date of acquisition, a credit rating of at least Baa1 from
Moody’s or BBB+ from S&P; 
  

 3 

 (m) repurchase and reverse repurchase agreements for securities described in
clauses (a) through (c) above with a financial institution described in clause (j) above; 
 (n)
asset-backed securities that are, on the date of acquisition, rated BBB+ by S&P or Baa1 by Moody’s; 

(o) money market funds and mutual funds consisting primarily of investments described in clauses (a) through
(n) above, in each case having a credit rating of at least Aaa from Moody’s or AAA from S&P, and in each case having at least US$500,000,000 of assets under management; and 

(p) other investments determined by the Company or any Subsidiary to entail credit risks not materially greater than those
associated with the foregoing investments and approved in writing by the Administrative Agent. 
 (b) Amendment to
Section 2.06(c). Section 2.06(c) of the Credit Agreement is amended and restated to read in its entirety as follows: 

“(c) Expiration Date. Each Letter of Credit shall expire at or prior to the close of business on the earlier of (i) the
date 18 months after the date of the issuance of such Letter of Credit (or, in the case of any renewal or extension thereof, 13 months after such renewal or extension) and (ii) the date that is five Business Days prior to the Maturity Date;
provided that any Letter of Credit may contain customary automatic renewal provisions agreed upon by the applicable Borrower and the applicable Issuing Bank pursuant to which the expiration date of such Letter of Credit shall automatically be
extended for a period of up to 13 months (but not to a date later than the date set forth in clause (ii) above), subject to a right on the part of such Issuing Bank to prevent any such renewal from occurring pursuant to the terms of such Letter
of Credit.” 
 (c) Amendment to Section 6.01. Section 6.01 of the Credit Agreement is amended by
(i) deleting the word “and” at the end of clause (p) thereof, (ii) replacing the period at the end of clause (q) thereof with “; and” and (iii) adding immediately after the end of clause (q) thereof
the following new clause (r): 
 “(r) Indebtedness under working capital facilities of Foreign Subsidiaries
(other than any such Foreign Subsidiary that is a Borrower hereunder) in an aggregate principal amount not to exceed $125,000,000 at any time outstanding.” 

(d) Amendment to Section 6.02. Section 6.02 of the Credit Agreement is amended by (i) deleting the word
“and” at the end of clause (l) thereof, (ii) replacing the period at the end of clause (m) thereof with “; and” and (iii) adding immediately after the end of clause (m) thereof the following new clause
(n): 
 “(n) Liens securing Indebtedness incurred pursuant to Section 6.01(r).” 

 

 4 

 (e) Amendment to Section 6.05. Section 6.05 of the Credit Agreement is
amended by amending and restating the proviso therein to read in its entirety as follows: 
 “provided that the
Company and any Subsidiary may make any Restricted Payments if (x) no Default shall have occurred and be continuing or would result therefrom and (y) the Company shall be in compliance with the covenant set forth in Section 6.10 as of
the end of the fiscal quarter of the Company most recently ended on or prior to the date of such Restricted Payment, giving pro forma effect to such Restricted Payment and any related incurrence of Indebtedness as if they had occurred on the last
day of such quarter.” 
 (f) Amendment to Section 6.08. Section 6.08(k) of the Credit Agreement is amended
by (x) deleting clause (iii) in the proviso therein, (y) renumbering clauses (iv), (v), (vi), (vii) and (viii) therein as clauses (iii), (iv), (v), (vi) and (vii), respectively, and (z) after giving effect to such
renumbering, amending and restating clause (vi) therein to read in its entirety as follows: 
 “(vi) the Company shall
have delivered to the Administrative Agent a certificate of a Financial Officer, certifying that all the requirements set forth in this clause (k) have been satisfied with respect thereto, together with reasonably detailed calculations
demonstrating satisfaction of the requirements set forth in subclauses (ii), (iii) and (iv) above”. 
 SECTION 3.
Representations, Warranties and Agreements. The Company, as to itself and each of the Subsidiaries, hereby represents and warrants to the Lenders that: 

(a) This Amendment has been duly executed and delivered by the Company and each other Borrower and (assuming due execution by the parties
hereto other than the Company and the other Borrowers) constitutes a legal, valid and binding obligation of the Company and each such Borrower, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization,
moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law. 

(b) Before and after giving effect to this Amendment, the representations and warranties set forth in Article III of the Credit Agreement
are true and correct in all material respects on and as of the Amendment Effective Date with the same effect as if made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date, in which
case they were true and correct as of such earlier date. 
 (c) As of the Amendment Effective Date, before and after giving
effect to this Amendment, no Default or Event of Default has occurred and is continuing. 
 SECTION 4. Effectiveness.
This Amendment shall become effective as of the first date (the “Amendment Effective Date”) on which: 
 (a)
the Administrative Agent (or its counsel) shall have received duly executed counterparts hereof that, when taken together, bear the authorized signatures of the Company, the other Borrowers and all the Lenders; 

 

 5 

 (b) the Administrative Agent (or its counsel) shall have received an instrument satisfactory
in form and substance to it and duly executed by each Subsidiary Loan Party consenting to the amendments effected by this Amendment and acknowledging that the Guarantee Agreement remains in full force and effect in accordance with its terms and
constitutes a guarantee of the Obligations as modified by this Amendment; 
 (c) The Administrative Agent shall have received
such documents and certificates as the Administrative Agent or its counsel may reasonably request relating to the organization, existence and good standing of each Loan Party, all in form and substance reasonably satisfactory to the Administrative
Agent and its counsel; 
 (d) The Administrative Agent shall have received (i) a favorable written opinion (addressed to
the Administrative Agent, the Lenders and the Issuing Banks and dated the Amendment Effective Date) of Wachtell, Lipton, Rosen & Katz, counsel for the Company, in form and substance reasonably satisfactory to the Administrative Agent, and
(ii) evidence reasonably satisfactory to the Administrative Agent as to the authorization of this Amendment; 
 (e) the
Administrative Agent shall have received a certificate, dated the Amendment Effective Date and signed by the President, a Vice President or a Financial Officer of the Company, confirming the accuracy of the representations and warranties set forth
in Section 3 hereof; 
 (f) the Administrative Agent shall have received, for the account of each Lender that executes and
delivers a copy of this Amendment, a consent fee in the amount of 0.25% of such Lender’s Commitment as of the Amendment Effective Date; and 

(g) the Administrative Agent shall have received all other fees and other amounts due and payable on or prior to the Amendment Effective
Date, including, to the extent invoiced, reimbursement or payment of all reasonable out-of-pocket expenses (including reasonable fees, charges and disbursements of counsel) required to be reimbursed or paid by the Company under the Credit Agreement;

 provided that if the Amendment Effective Date shall not have occurred on or before August 31, 2010, this Amendment shall
terminate and be of no further force and effect. The Administrative Agent shall notify the Company and the Lenders of the Amendment Effective Date, and such notice shall be conclusive and binding. 

SECTION 5. Effect of this Amendment. (a) Except as expressly set forth herein, this Amendment shall not by implication or
otherwise limit, impair, constitute a waiver of, or otherwise affect the rights and remedies of the Agents, the Issuing Banks or the Lenders under the Credit Agreement or any other Loan Document, and shall not alter, modify, amend or in any way
affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect (it being
understood and agreed that all interest and fees accruing under the Credit 
  

 6 

 
Agreement in respect of periods prior to the Amendment Effective Date will accrue at the rates specified in the Credit Agreement prior to its amendment by this Amendment and be payable at the
times provided in the Credit Agreement). Nothing herein shall be deemed to entitle any Loan Party to a consent to, or a waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained
in the Credit Agreement or any other Loan Document in similar or different circumstances. 
 (b) On and after the Amendment
Effective Date, each reference in the Credit Agreement to “this Agreement”, “herein”, “hereunder”, “hereto”, “hereof” and words of similar import shall, unless the context otherwise requires, refer
to the Credit Agreement as amended hereby, and each reference to the Credit Agreement in any other Loan Document shall be deemed to be a reference to the Credit Agreement as amended hereby. This Amendment shall constitute a “Loan Document”
for all purposes of the Credit Agreement and the other Loan Documents. 
 SECTION 6. Applicable Law. THIS AMENDMENT
SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. 
 SECTION 7. Counterparts.
This Amendment may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original but all of which, when taken together, shall constitute a single instrument. Delivery of an
executed counterpart of a signature page of this Amendment by telecopy or other electronic transmission shall be effective as delivery of a manually executed counterpart hereof. 

SECTION 8. Fees and Expenses. The Company agrees to reimburse the Administrative Agent for its reasonable out-of-pocket expenses
in connection with this Amendment, including the reasonable fees, charges and disbursements of Cravath, Swaine & Moore LLP, counsel for the Administrative Agent. All fees shall be payable in immediately available funds and shall not be
refundable. 
  

 7 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by
their respective authorized officers as of the date first above written. 
  

			
	EXPEDIA, INC., a Delaware corporation,
		
	 by:
	 	
		 	     /s/ Dara Khosrowshahi

		 	 Name: Dara Khosrowshahi

Title: Chief Executive Officer

	
	EXPEDIA, INC., a Washington corporation,
		
	 by:
	 	
		 	     /s/ Michael B. Adler

		 	 Name: Michael B. Adler

Title: Executive Vice President and Chief Financial Officer

	
	TRAVELSCAPE, LLC,
		
	 by:
	 	
		 	     /s/ Michael B. Adler

		 	 Name: Michael B. Adler

Title: Executive Vice President and Chief Financial Officer

	
	TRIPADVISOR LLC,
		
	 by:
	 	
		 	     /s/ Michael B. Adler

		 	 Name: Michael B. Adler

Title: Executive Vice President and Chief Financial Officer

	
	HOTWIRE, INC.,
		
	 by:
	 	
		 	     /s/ Michael B. Adler

		 	 Name: Michael B. Adler

Title: Executive Vice President and Chief Financial Officer

			
	JPMORGAN CHASE BANK, N.A., individually
and as Administrative Agent,
		
	 by:
	 	
		 	     /s/ Peter B. Thauer

		 	 Name: Peter B. Thauer

Title: Executive Director

 SIGNATURE PAGE TO 

FIRST AMENDMENT TO 

EXPEDIA, INC. CREDIT AGREEMENT 
  

			
	Name of Institution:        Bank of America, N.A.
		
	 by:
	 	
		 	     /s/ Michael K. Makaitis

		 	 Name: Michael K. Makaitis

Title: Vice President

  

			
	Name of
Institution:1
		
	 by:
	 	
		
		 	  

		 	 Name:

Title:

 

	1
	 For any Lender requiring a second signature line. 

 SIGNATURE PAGE TO 

FIRST AMENDMENT TO 

EXPEDIA, INC. CREDIT AGREEMENT 
  

			
	Name of Institution:         The Bank of Tokyo-Mitsubishi UFJ, Ltd.
		
	 by:
	 	
		 	     /s/ Christine Howatt

		 	 Name: Christine Howatt

Title: Authorized Signatory

	
	Name of
Institution:2
		
	 by:
	 	
		
		 	  

		 	 Name:

Title:

 

	2
	 For any Lender requiring a second signature line. 

 SIGNATURE PAGE TO 

FIRST AMENDMENT TO 

EXPEDIA, INC. CREDIT AGREEMENT 
  

			
	Name of Institution:        Barclays Bank PLC
		
	 by:
	 	
		 	     /s/ Ritam Bhalla

		 	 Name: Ritam Bhalla
 Title:
Vice President

 SIGNATURE PAGE TO 

FIRST AMENDMENT TO 

EXPEDIA, INC. CREDIT AGREEMENT 
  

			
	BNP Paribas
		
	 by:
	 	
		 	     /s/ Nuala Marley

		 	 Name: Nuala Marley
 Title:
Managing Director

  

			
	BNP Paribas
		
	 by:
	 	
		 	     /s/ Maria Mulic

		 	 Name: Maria Mulic
 Title:
Vice President

 SIGNATURE PAGE TO 

FIRST AMENDMENT TO 

EXPEDIA, INC. CREDIT AGREEMENT 
  

			
	Name of Institution:        Mizuho Corporate Bank Ltd.
		
	 by:
	 	
		 	     /s/ Betram H. Tang

		 	 Name: Betram H. Tang
 Title:
Authorized Signatory

 SIGNATURE PAGE TO 

FIRST AMENDMENT TO 

EXPEDIA, INC. CREDIT AGREEMENT 
  

			
	THE ROYAL BANK OF SCOTLAND PLC
		
	 by:
	 	
		 	     /s/ Tracy Rahn

		 	 Name: Tracy Rahn
 Title:
Vice President

 SIGNATURE PAGE TO 

FIRST AMENDMENT TO 

EXPEDIA, INC. CREDIT AGREEMENT 
  

			
	Name of Institution:        Sumitomo Mitsui Banking Corporation
		
	 by:
	 	
		 	     /s/ William M. Ginn

		 	 Name: William M. Ginn

Title: Executive Officer

	
	Name of
Institution:3
		
	 by:
	 	
		
		 	  

		 	 Name:

Title:

 

	3
	 For any Lender requiring a second signature line. 

 SIGNATURE PAGE TO 

FIRST AMENDMENT TO 

EXPEDIA, INC. CREDIT AGREEMENT 
  

			
	Name of Institution: U.S. BANK, NATIONAL ASSOCIATION
		
	 by:
	 	
		 	     /s/ Mehrasa Raygani

		 	 Name: Mehrasa Raygani

Title: Senior Vice President

	
	Name of
Institution:4
		
	 by:
	 	
		
		 	  

		 	 Name:

Title:

 

	4
	 For any Lender requiring a second signature line.Amended and Restated Relationship Agreement

 Exhibit 10.1 

EXECUTION COPY 

AMENDED AND RESTATED RELATIONSHIP AGREEMENT 

by and between 

MISYS PLC 

and 

ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC. 

dated as of August 20, 2010 

 CONTENTS 

 

			
	Clause	  	Page
		
	 1.      INTERPRETATION
	  	3
	 2.      DURATION
	  	8
	 3.      BOARD REPRESENTATION
	  	8
	 4.      ARSENAL CHAIRMAN
	  	10
	 5.      OPERATING REQUIREMENTS
	  	11
	 6.      PROVISION OF INFORMATION
	  	11
	 7.      TRADING IN ARSENAL AND MANCHESTER SHARES
	  	12
	 8.      ANNOUNCEMENTS
	  	12
	 9.      CONFIDENTIALITY
	  	12
	 10.    WAIVER AND AMENDMENT
	  	13
	 11.    STANDSTILL
	  	14
	 12.    TERMINATION
	  	16
	 13.    GENERAL
	  	16
	 14.    NOTICES
	  	17
	 15.    GOVERNING LAW
	  	18
	 16.    ENFORCEMENT
	  	18

  

 2 

 THIS AMENDED AND RESTATED RELATIONSHIP AGREEMENT dated as of August 20, 2010, is made and
entered into 
 BETWEEN: 
  

	(1)	Misys plc, a public limited company incorporated under the laws of England and Wales (Manchester); and 

 

	(2)	Allscripts-Misys Healthcare Solutions, Inc., a Delaware corporation (Arsenal); 

together, the Parties. 

WHEREAS: 
  

	(A)	Manchester acquired direct and indirect ownership of approximately fifty-four and one-half percent (54.5%) of the then issued and outstanding Arsenal Shares
pursuant to an Agreement and Plan of Merger, dated March 17, 2008, entered into by and among Manchester, Misys Healthcare Systems, LLC, Arsenal Healthcare Solutions Inc. and Patriot Merger Company, LLC (the Merger);

  

	(B)	Manchester and Arsenal entered into the Original Relationship Agreement (as defined below) to govern the relationship between them and to ensure that, among other
things, Manchester would continue to comply with its UK Regulatory Requirements and Arsenal would continue to comply with its US Regulatory Requirements following the Merger; 

 

	(C)	Manchester and Arsenal entered into a Framework Agreement dated as of June 9, 2010 (the Framework Agreement) pursuant to which Manchester and Arsenal
agreed, among other things and subject to certain conditions, to reduce Manchester’s existing indirect shareholding in Arsenal through (i) a repurchase by Arsenal of certain Arsenal Shares held indirectly by Manchester through its
subsidiaries Misys Patriot Limited (MPL), Kapiti Limited (Kapiti) and ACT Sigmex Limited (ACTS) and (ii) a secondary public offering by Kapiti and ACTS of additional Arsenal Shares (the transactions described in clauses
(i) and (ii), the Coniston Transaction); 

  

	(D)	Arsenal has entered into an Agreement and Plan of Merger dated as of June 9, 2010 (the Merger Agreement) with Eclipsys Corporation, a Delaware corporation
(Emerald), pursuant to and subject to the terms and conditions of which the stockholders of Emerald would receive newly issued Arsenal Shares as consideration (the Emerald Transaction), it being understood that under no circumstances
would the Emerald Transaction be consummated prior to the closing of the Coniston Transaction (the Coniston Closing); and 

  

	(E)	In connection with and subject to the Coniston Closing, Manchester and Arsenal desire to amend and restate the Original Relationship Agreement in accordance with the
terms and conditions set forth in this Agreement. 

 NOW, THEREFORE, in consideration of the representations, warranties,
covenants and agreements set forth herein and in the Framework Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of Manchester and Arsenal hereby agrees that the Original
Relationship Agreement is hereby amended and restated in its entirety as follows: 
  

	1.	INTERPRETATION 

  

	1.1	In this Agreement: 

  

 3 

 13D Group means any group of Persons that is required under Section 13(d) of the
Exchange Act and the rules and regulations thereunder to file a statement on Schedule 13D with the SEC as a “person” within the meaning of Section 13(d)(3) of the Exchange Act with respect to the Equity Securities of Arsenal.

 Acquired Person shall have the meaning ascribed to such term in Section 11.1 hereof. 

ACTS means ACT Sigmex Limited, a limited company formed under the Laws of England and Wales and a subsidiary of Manchester.

 Affiliate means, with respect to any Person, any other Person that directly, or indirectly through one or more
intermediaries, Controls or is Controlled by, or is under common Control with, such Person. For purposes of this Agreement, Manchester and its Subsidiaries, on the one hand, and Arsenal and its Subsidiaries, on the other hand, shall not be deemed
Affiliates of each other. 
 Agreement means this Amended and Restated Relationship Agreement. 

Arsenal shall have the meaning ascribed to such term in the first paragraph of this Agreement. 

Arsenal Board shall have the meaning ascribed to such term in Section 3.1 hereof. 

Arsenal Chairman shall have the meaning ascribed to such term in Section 4.1 hereof. 

Arsenal Non-Executive Chairman Term shall have the meaning ascribed to such term in Section 4.4 hereof. 

Arsenal Shares means the issued and outstanding shares of common stock of Arsenal, par value $0.01 per share. 

beneficially own (or any similar phrase) shall have the meaning set forth in Rule 13d-3 under the Exchange Act. 

business day means any day except Saturday, Sunday or any day on which banks or stock exchanges are generally not open for business
in the City of New York, New York or the City of London, England. 
 Chairman Agreement means the Employment Agreement,
dated as of the date hereof, by and between Arsenal and Philip M. Pead, which shall be effective as of the Emerald Closing. 

Companies Act (UK) means the Companies Act 2006, as amended from time to time. 

Confidential Information shall have the meaning ascribed to such term in Section 9.1 hereof. 

Coniston Closing shall have the meaning ascribed to such term in the Recitals hereof. 

Coniston Closing Percentage means the number of Arsenal Shares held by Manchester and its Subsidiaries immediately after the
Coniston Closing expressed as a percentage of the aggregate number of the then issued and outstanding Arsenal Shares. 

Coniston Transaction shall have the meaning ascribed to such term in the Recitals hereof. 

Contingent Repurchase shall have the meaning ascribed to such term in the Framework Agreement. 

Contingent Repurchase Closing means the consummation of the Contingent Repurchase. 

 

 4 

 Contingent Repurchase Closing Percentage means the number of Arsenal Shares held by
Manchester and its Subsidiaries immediately after the Contingent Repurchase Closing expressed as a percentage of the aggregate number of the then issued and outstanding Arsenal Shares. 

Control (including, with its correlative meanings, Controlled by and under common Control with) means, with respect
to any Person, any of the following: (a) ownership, directly or indirectly, by such Person of equity securities entitling it to exercise in the aggregate more than fifty percent (50%) of the voting power of the entity in question or
(b) the possession by such Person of the power, directly or indirectly, to elect a majority of the board of directors (or equivalent governing body) of the entity in question. 

Disclosing Party shall have the meaning ascribed to such term in Section 9.1 hereof. 

Disclosure and Transparency Rules (UK) means the disclosure and transparency rules of the FSA. 

Emerald shall have the meaning ascribed to such term in the Recitals hereof. 

Emerald Closing means the consummation of the Emerald Transaction. 

Emerald Closing Percentage means the number of Arsenal Shares held by Manchester and its Subsidiaries immediately after the Emerald
Closing expressed as a percentage of the aggregate number of the then issued and outstanding Arsenal Shares. 
 Emerald
Designee shall have the meaning ascribed to such term in Section 4.2 hereof. 
 Emerald Transaction shall
have the meaning ascribed to such term in the Recitals hereof. 
 Equity Security means any Arsenal Shares or other equity
security of Arsenal, or option, warrant, right or other security convertible, or exercisable into or exercisable for equity securities of Arsenal. 

Excepted Transaction shall have the meaning ascribed to such term in Section 11.1 hereof. 

Exchange Act means the U.S. Securities Exchange Act of 1934, as amended. 

FINRA means the U.S. Financial Industry Regulatory Authority. 

First Arsenal Chairman means Marcel L. Gamache. 

Framework Agreement shall have the meaning ascribed to such term in the Recitals hereof. 

FSA means the UK Financial Services Authority. 

Governmental Authority means any federation, nation, state, sovereign or government, any federal, supranational, regional, state or
local political subdivision, any governmental or administrative body, instrumentality, department or agency or any court, administrative hearing body, commission or other similar dispute resolving panel or body, and any other entity exercising
executive, legislative, judicial, regulatory or administrative functions of a government. 
 Governmental Authorization
means any permit, consent, approval, authorization, waiver, grant, concession, license, exemption or order of, registration, certificate, declaration or filing with, or report or notice to, any Governmental Authority. 

Independent Director means a director who, with respect to Arsenal, meets the criteria for independence established by Nasdaq.

  

 5 

 Kapiti means Kapiti Limited, a limited company formed under the Laws of England and
Wales and a subsidiary of Manchester. 
 Law means all applicable provisions of all (a) constitutions, treaties,
statutes, laws (including common law), rules, regulations, ordinances or codes of any Governmental Authority, and (b) orders, decisions, injunctions, judgments, awards, decrees and Governmental Authorizations of any Governmental Authority.

 Listing Rules (UK) means the listing rules of the FSA. 

LSE means London Stock Exchange plc. 

Manchester shall have the meaning ascribed to such term in the first paragraph of this Agreement. 

Manchester Directors shall have the meaning ascribed to such term in Section 3.1 hereof. 

Manchester’s General Counsel means the Manchester executive who holds that title at any given time. 

Manchester Group means Manchester and its Subsidiaries from time to time (excluding Arsenal and its Subsidiaries from time to
time). 
 Manchester Marks shall have the meaning ascribed to such term in Section 11.3(b) hereof. 

Maximum Arsenal Percentage shall have the meaning ascribed to such term in Section 11.1 hereof. 

Merger shall have the meaning ascribed to such term in the Recitals hereof. 

Merger Agreement shall have the meaning ascribed to such term in the Recitals hereof. 

MOSS shall have the meaning ascribed to such term in Section 11.4 hereof. 

MPL means Misys Patriot Limited, a limited company formed under the Laws of England and Wales and a subsidiary of Manchester.

 Nasdaq means the Nasdaq National Market. 

Original Relationship Agreement means, collectively, the Relationship Agreement between the Parties dated as of March 17,
2008, as amended by the First Amendment to the Relationship Agreement, dated as of August 14, 2008, and the Second Amendment to the Relationship Agreement, dated as of January 5, 2009. 

Parties means Manchester and Arsenal, with each being a Party. 

Person means any natural person, business trust, corporation, partnership, limited liability company, joint stock company,
proprietorship, association, trust, joint venture, unincorporated association or any other legal entity of whatever nature organized under any applicable Law, an unincorporated organization or any Governmental Authority. 

Representatives shall have the meaning ascribed to such term in Section 9.1 hereof. 

Restricted Activities shall have the meaning ascribed to such term in Section 11.3(a) hereof. 

SEC means the U.S. Securities and Exchange Commission. 

Second Arsenal Chairman shall have the meaning ascribed to such term in Section 4.3 hereof. 

 

 6 

 Standstill Period shall have the meaning ascribed to such term in
Section 11.1 hereof. 
 Subsidiary means, with respect to any Person, another Person that, at the time of
determination, directly or indirectly, through one or more intermediaries, is Controlled by such first Person. 

Transaction shall have the meaning ascribed to such term in Section 11.1 hereof. 

UKLA means the UK Listing Authority. 

UK Regulatory Requirements means Manchester’s obligations under, inter alia, the Companies Act (UK), the Listing Rules (UK)
and the Disclosure and Transparency Rules (UK) or any similar Law in effect now or in the future. 
 UK Takeover Code
means the City Code on Takeovers and Mergers issued by the Panel on Takeovers and Mergers. 
 US Regulatory Requirements
means Arsenal’s obligations under, inter alia, the U.S. Securities Act of 1933, as amended, the Exchange Act, FINRA rules and regulations and the General Corporation Law of the State of Delaware or any similar Law in effect now or in the
future. 
 Voting Securities means at any time any securities entitled to vote generally in the election of directors of
Arsenal or its successors; provided, that for purposes of this definition any securities which at such time are convertible or exchangeable into or exercisable for Arsenal Shares shall be deemed to have been so converted, exchanged or
exercised. 
  

	1.2	In this Agreement any reference, express or implied, to a Law includes: 

  

	 	(a)	that Law, as amended, extended or applied by or under any other Law (before, on or after execution of this Agreement); 

 

	 	(b)	any Law which that Law re-enacts (with or without modification); and 

  

	 	(c)	any subordinate legislation made (before, on or after execution of this Agreement) under that Law, including (where applicable) that Law as amended, extended or applied
as described in paragraph (a) above, or under any Law which it re-enacts as described in paragraph (b) above, 

and Law includes any rule, regulation or requirement of the SEC, General Corporation Law of the State of Delaware, FINRA, UK Listing
Authority, London Stock Exchange, FSA, the UK Takeover Code and any other body or authority acting under the authority of any Law and any legislation in any jurisdiction. 

 

	1.3	Unless the context of this Agreement otherwise clearly requires, (i) references to the plural include the singular, and references to the singular include the
plural, (ii) references to a Person are also to its permitted successors and assigns, (iii) references to any gender include the other genders, (iv) the words “include,” “includes” and “including” do not
limit the preceding terms or words and shall be deemed to be followed by the words “without limitation”, (v) the terms “hereof”, “herein”, “hereunder”, “hereto” and similar terms in this
Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement, (vi) the terms “day” and “days” mean and refer to calendar day(s) and (vii) the terms “year” and
“years” mean and refer to calendar year(s). 

  

	1.4	The headings and captions in this Agreement and in the table of contents are included for convenience of reference only and shall be ignored in the construction or
interpretation of this Agreement. 

  

 7 

	2.	DURATION 

 This Agreement
shall take effect immediately on the date hereof and, except for the specific rights and obligations set forth herein that by their terms are intended to terminate earlier, shall continue indefinitely. 

 

	3.	BOARD REPRESENTATION 

  

	3.1	The Arsenal board of directors (the Arsenal Board) shall consist of a number of directors fixed from time to time by the Arsenal Board. Manchester shall have the
right to nominate for election to the Arsenal Board two (2) directors (the Manchester Directors), one of whom shall serve on the Arsenal Nominating and Governance Committee; provided, however, that the Manchester Director
serving on the Arsenal Nominating and Governance Committee shall be an Independent Director and if neither Manchester Director is an Independent Director, then neither of the Manchester Directors shall serve on the Arsenal Nominating and Governance
Committee; provided, further, that Manchester’s right to nominate two (2) Manchester Directors for election to the Arsenal Board shall be reduced as follows: 

 

	 	(i)	if, at any time, Manchester shall own, directly or indirectly, for more than ten (10) consecutive business days, less than 15.5 million Arsenal Shares (as
adjusted pursuant to Section 13.6) but continues to own, directly or indirectly, such number of Arsenal Shares that as a percentage of the then outstanding Arsenal Shares is equal to or greater than 5.0%, the number of Manchester
Directors shall be permanently (unless further reduced pursuant to clause (ii) below) reduced to one (which individual shall not serve on the Arsenal Nominating and Governance Committee); 

 

	 	(ii)	if, at any time, Manchester shall own, directly or indirectly, for more than ten (10) consecutive business days, less than 5.0% of the then outstanding Arsenal
Shares, Manchester shall permanently cease to have a right to nominate any Manchester Directors to the Arsenal Board; 

  

	 	(iii)	if, at any time, Manchester takes an action specified in Sections 11.1(iii), 11.1(iv) or 11.1(viii) (or the board of directors of Manchester
formally resolves to take an action specified in Section 11.1(xi) with regard to any action specified in Sections 11.1(iii), 11.1(iv) or 11.1(viii)) at a time when it has the right to designate a Manchester Director
but no Manchester Director is then serving on the Arsenal Board, Manchester shall permanently cease to have a right to nominate any Manchester Directors to the Arsenal Board; and 

 

	 	(iv)	if, at any time, a Manchester Director resigns from, or refuses to stand for re-election to, the Arsenal Board (A) after notifying the Arsenal Board in writing
that the reason for such resignation or refusal to stand for re-election is a disagreement with Arsenal or (B) if no such written notification is provided prior to such resignation or refusal to stand for re-election, if such Manchester
Director does not furnish Arsenal with a letter indicating disagreement with any disclosure by Arsenal pursuant to Item 5.02(a)(1) of Form 8-K, then Manchester shall permanently cease to have a right to nominate a replacement for such
Manchester Director. 

  

	3.2	 The Manchester Directors who will serve immediately following the date hereof and until the next annual meeting of stockholders shall be Stephen Wilson
and John King. Thereafter, Manchester shall provide the Arsenal Manchester Nominating Committee and Nominating and Governance Committee at least one hundred twenty (120) days prior to the anniversary date of the immediately preceding annual
meeting, with the names of the Manchester Directors that Manchester has a right to nominate pursuant to Section 3.1, if any, and the Arsenal Manchester Nominating Committee or Nominating and Governance Committee, as applicable, shall
then recommend such Manchester Directors to the Arsenal Board who 

  

 8 

	 	 
shall in turn recommend such Manchester Directors for election by Arsenal stockholders. For so long as Manchester retains the right to nominate any Manchester Directors pursuant to
Section 3.1, Arsenal shall use commercially reasonable efforts to (a) ensure that the Arsenal Nominating and Governance Committee (other than the Manchester Director serving thereon, if any) recommends to the Arsenal Board such
Manchester Directors for election, (b) ensure that the Arsenal Board (other than any Manchester Director serving thereon) recommends to the stockholders of Arsenal such Manchester Directors for election and (c) cause the Arsenal Board to
use reasonable efforts to solicit from the stockholders of Arsenal eligible to vote for the election of directors proxies in favor of such Manchester Directors. For so long as Manchester retains the right to nominate any Manchester Directors
pursuant to Section 3.1, if Manchester shall fail to provide the Arsenal Manchester Nominating Committee and Nominating and Governance Committee with the names of the Manchester Director nominees as provided above, it shall be deemed
that the then serving Manchester Directors shall be the Manchester nominees for election. If at any time a Manchester Director resigns or is removed from the Arsenal Board (other than pursuant to Section 3.3) and at such time Manchester
would have a right to nominate such director pursuant to Section 3.1, Manchester shall be entitled to designate a replacement Manchester Director to be appointed by the Arsenal Board to fill such vacancy and serve on the Arsenal Board
until the next annual meeting of stockholders. 

  

	3.3	In the case of any reduction in Manchester’s ownership of Arsenal Shares such that Manchester’s right to nominate Manchester Directors is reduced as set forth
in Section 3.1(i) or 3.1(ii), within three (3) business days thereafter, (a) Manchester shall designate the appropriate number of Manchester Directors to resign immediately and shall use its commercially reasonable
efforts to cause such Manchester Directors to so resign, (b) the Arsenal Board (following the recommendation of the Arsenal Nominating and Governance Committee) shall appoint replacement directors to serve for the remainder of the term of such
Manchester Directors and (c) where Manchester’s right to nominate Manchester Directors is reduced to one as set forth in Section 3.1(i), Manchester shall use its commercially reasonable efforts to cause the Manchester Director
then serving on the Arsenal Nominating and Governance Committee to resign immediately from his position as a member of such committee. 

  

	3.4	Subject to compliance with Arsenal’s conflict of interest policy generally applicable to all Arsenal directors, the Manchester Directors shall be furnished with
all information that is provided to any other directors of Arsenal (in their capacities as such) at the same time as such information is furnished to such other directors. 

 

	3.5	At any annual meeting of Arsenal stockholders held during calendar year 2010 and at the first meeting of Arsenal stockholders held to elect directors in calendar year
2011, Manchester will cause its Voting Securities to be present for quorum purposes and will vote or cause to be voted all Voting Securities beneficially owned by any member of the Manchester Group in favor of all the directors recommended by the
Arsenal Nominating and Governance Committee and the Arsenal Board. After the date of the first meeting of Arsenal stockholders held to elect directors in calendar year 2011, Manchester may vote or cause to be voted all Voting Securities beneficially
owned by any member of the Manchester Group in any manner Manchester deems appropriate, including against one or more of the directors recommended by the Arsenal Nominating and Governance Committee and the Arsenal Board. 

 

	3.6	 At any annual meeting of Arsenal stockholders held during calendar year 2010 and at the first meeting of Arsenal stockholders held to elect directors
in calendar year 2011, except as set forth in Section 3.3 or in accordance with the recommendation of the Arsenal Nominating and Governance Committee or the Arsenal Board or in any case of removal “for cause”, Manchester will
not vote (and will cause not to be voted) any Voting Securities beneficially owned by any member of the Manchester Group in favor of the 

 

 9 

	 	 
removal from the Arsenal Board of any director nominated for election to the Arsenal Board by the Arsenal Nominating and Governance Committee and will cause all Voting Securities beneficially
owned by any member of the Manchester Group to be voted against such removal. For avoidance of doubt, in any case of removal “for cause” or if so recommended by the Arsenal Nominating and Governance Committee or the Arsenal Board,
Manchester may, but shall not be required to, vote (or cause to be voted) any Voting Securities beneficially owned by any member of the Manchester Group in favor of the removal from the Arsenal Board of any director nominated for election to the
Arsenal Board by the Arsenal Nominating and Governance Committee. 

  

	4.	ARSENAL CHAIRMAN 

  

	4.1	During the Arsenal Non-Executive Chairman Term (as defined below), (x) except as set forth in the second sentence of Section 4.2 below, the Chairman of
Arsenal shall be a newly created position of non-executive Chairman of the Arsenal Board (the Arsenal Chairman) and (y) the positions of the Arsenal Chairman (or Chairman of the Arsenal Board, as the case may be) and the Chief Executive
Officer of Arsenal shall be held by different persons. Arsenal shall take such actions as are necessary so as to amend the Bylaws of Arsenal to give immediate effect to the foregoing. 

 

	4.2	The First Arsenal Chairman shall serve in such role for a term that expires on the earlier of (x) the date that is two (2) years following the date hereof and
(y) the date on which the Emerald Closing occurs; provided, however, that if during such term (i) the First Arsenal Chairman resigns, dies or is otherwise unable to continue to serve in such position or is removed (which
removal may only be carried out by the affirmative vote of no less than a two-thirds majority of the members of the Arsenal Board) and (ii) at the time such vacancy is created Manchester has the right to nominate one or more Manchester
Directors to the Arsenal Board in accordance with Section 3.1, then a replacement for the First Arsenal Chairman shall be elected by the affirmative vote of no less than a two-thirds majority of the members of the Arsenal Board to serve
out the remaining term of such two (2) year period (and, for the purposes of this Section 4, such replacement shall also be referred to as the First Arsenal Chairman). In the event the term of the First Arsenal Chairman expires on
the date of the Emerald Closing in accordance with clause (y) of the immediately preceding sentence, the individual designated by the Arsenal Board in accordance with terms of the Merger Agreement to serve as the Chairman of the Arsenal Board
(the Emerald Designee) shall serve as the Chairman of the Arsenal Board for a term of three (3) years from the date of the Emerald Closing in accordance with the terms of the Merger Agreement, the Bylaws of Arsenal and the Chairman
Agreement; provided, however, that if during such term (i) the Emerald Designee resigns, dies or is otherwise unable to continue to serve in such position or is removed (which removal may only be carried out by the affirmative
vote of no less than a two-thirds majority of the entire Arsenal Board) and (ii) at the time such vacancy is created Manchester has the right to nominate one or more Manchester Directors to the Arsenal Board in accordance with
Section 3.1, then a replacement for the Emerald Designee shall be elected by the affirmative vote of no less than a two-thirds majority of the entire Arsenal Board to serve out the remaining term of such three (3) year period (and,
for the purposes of this Section 4, such replacement shall also be referred to as the Emerald Designee). 

  

	4.3	 If at the expiration of the (x) two (2) year term of the First Arsenal Chairman or (y) the term during which the Emerald Designee serves
as the Arsenal Chairman, as the case may be, Manchester continues to have the right to nominate one or more Manchester Directors to the Arsenal Board in accordance with Section 3.1, then the next Arsenal Chairman shall be elected (or the
First Arsenal Chairman or the Emerald Designee, as the case may be, shall be re-elected) (in either case, the Second Arsenal Chairman) by the affirmative vote of no less than a two-thirds majority of the entire Arsenal Board. The term of
appointment of the Second Arsenal Chairman shall be for a period of not less than two (2)

  

 10 

	 	 
years following the date of such election (or re-election). During the Arsenal Non-Executive Chairman Term, the removal of the Second Arsenal Chairman shall require the affirmative vote of no
less than a two-thirds majority of the entire Arsenal Board. 

  

	4.4	For purposes of this Section 4, the Arsenal Non-Executive Chairman Term shall mean the period between the date hereof and the first to occur of
(i) the date on which Manchester ceases to have the right to nominate any Manchester Directors and (ii) the expiration of the two (2) year term of the Second Arsenal Chairman (or any replacement therefor). 

 

	5.	OPERATING REQUIREMENTS 

  

	5.1	For so long as Manchester continues to own, directly or indirectly, such number of Arsenal Shares that as a percentage of the then outstanding Arsenal Shares is equal
to or greater than 5.0%, each of Arsenal and Manchester agrees to use its commercially reasonable efforts to ensure that it and each of its Subsidiaries continues to comply with all applicable US Regulatory Requirements and UK Regulatory
Requirements from time to time (as applicable). 

  

	5.2	For so long as Manchester continues to own, directly or indirectly, such number of Arsenal Shares that as a percentage of the then outstanding Arsenal Shares is equal
to or greater than 5.0%, other than with the prior written consent of Manchester, Arsenal shall not treat itself as other than a corporation for U.S. federal income tax purposes. 

 

	6.	PROVISION OF INFORMATION 

  

	6.1	Arsenal shall provide, and shall cause its Subsidiaries to provide, Manchester with all information (including financial information prepared in accordance with
International Financial Reporting Standards in a form consistent with past practice) as Manchester reasonably requires to comply with all applicable UK Regulatory Requirements for any period as to which Manchester is required to account for its
investment in Arsenal by full consolidation or by the equity method of accounting, which in any event shall include such information relating to the period from the commencement of Arsenal’s fiscal year 2011 until the date hereof.

  

	6.2	Subject to applicable Laws and attorney-client privilege, and so long as such disclosure does not result in any reporting or disclosure obligations for Arsenal under US
Regulatory Requirements, the Manchester Directors shall be entitled to disclose to such of Manchester’s officers, directors, employees and advisers who have a reasonable need to receive such disclosure in connection with Manchester’s
investment in Arsenal, any information in such Manchester Director’s possession however obtained that relates to Arsenal or any of its Subsidiaries; provided, that Manchester shall ensure that each such recipient is aware, where such is
the case, of the confidential nature of such information and, in any such case, Manchester shall use commercially reasonable efforts to cause each such recipient to treat such information as Confidential Information in accordance with
Section 9; provided, further, that if disclosure of any such information to Manchester would result in the loss of attorney-client privilege to Arsenal and if entering into a joint defense agreement would protect such
privilege, Arsenal and Manchester shall negotiate in good faith an appropriate joint defense agreement as promptly as practicable in order to permit such disclosure to Manchester. Manchester shall be responsible for any breach of confidentiality by
such recipients. 

  

	6.3	Manchester acknowledges that the information disclosed under Section 6.1 may be inside information in relation to Arsenal and undertakes that it shall (and
shall use all powers vested in it to procure, so far as it is legally able, that each of its Subsidiaries shall) comply with all applicable Laws in relation to the disclosure or use of such information until such information ceases to be inside
information in relation to Arsenal. 

  

 11 

	6.4	Neither Manchester nor Arsenal shall be obliged to disclose any information under this Section 6 if and to the extent that such disclosure would be
prohibited by Law. 

  

	6.5	For the purposes of this Section 6, Arsenal’s obligations to disclose information to Manchester will be satisfied when the information is received by
Manchester’s General Counsel or such other executive officer of Manchester as Manchester may designate from time to time. 

  

	7.	TRADING IN ARSENAL AND MANCHESTER SHARES 

For so long as Manchester continues to own, directly or indirectly, such number of Arsenal Shares that as a percentage of the then
outstanding Arsenal Shares is equal to or greater than 5.0%, Arsenal and Manchester agree to work together in good faith to, where appropriate: 
  

	 	(a)	maintain all existing internal controls for monitoring and regulating the appropriate flow of inside information between Arsenal and Manchester; and

  

	 	(b)	maintain all agreed protocols for trading in Arsenal Shares and shares of Manchester common stock. 

 

	8.	ANNOUNCEMENTS 

 Except as
required by Law or by the requirements of any securities exchange on which the securities of a Party are listed, the Parties shall cooperate as to the timing and contents of any press release or public announcement in respect of this Agreement or
the transactions contemplated hereby or any communication with any news media with respect thereto. 
  

	9.	CONFIDENTIALITY 

  

	9.1	Each Party shall hold and not disclose, and shall cause its employees, officers, directors, agents and other representatives (Representatives) and any of its
Subsidiaries or other controlled Affiliates or any of their respective Representatives to hold and not disclose, all material non-public information and any other information of a secret or confidential nature (including all business, operational,
customer, employee, technological, financial, commercial and other proprietary information and materials) (the Confidential Information) received by it from the other Party or any of its Subsidiaries or other Affiliates or any of their
respective Representatives (the Disclosing Party). 

  

	9.2	Except as expressly authorized by prior written consent of (i) Manchester, in any case where Manchester or any of its Subsidiaries or other controlled Affiliates,
or any of their respective Representatives, is the Disclosing Party or (ii) Arsenal, in any case where Arsenal or any of its Subsidiaries or other controlled Affiliates, or any of their respective Representatives, is the Disclosing Party, the
receiving Party shall and shall cause its Representatives to: 

  

	 	(a)	limit access to any Confidential Information of the Disclosing Party received by it to its and its Affiliates’ Representatives who have a reasonable need to know
such Confidential Information; 

  

 12 

	 	(b)	advise such Representatives having access to the Confidential Information of the Disclosing Party of the proprietary nature thereof and of the obligations set forth in
this Agreement and confirm their agreement that they will be bound by such obligations; 

  

	 	(c)	safeguard all Confidential Information of the Disclosing Party received using a reasonable degree of care, but not less than that degree of care used by the receiving
Party in safeguarding its own similar information or material; 

  

	 	(d)	comply in all material respects with all applicable Laws relating to maintaining the confidentiality of the Confidential Information of the Disclosing Party; and

  

	 	(e)	not reproduce, exploit or, except as set forth in Section 3.4 and Section 6, use any Confidential Information of the Disclosing Party or
disclose the Confidential Information of the Disclosing Party to any other Person. 

  

	9.3	Nothing in Section 8 or this Section 9 shall prevent any announcement being made or any Confidential Information being disclosed:

  

	 	(a)	with the prior written approval of the other Party, which in the case of any announcement shall not be unreasonably withheld or delayed; or 

 

	 	(b)	to the extent required by Law or the Disclosure and Transparency Rules (UK) or by the FSA, the UKLA, the LSE, the UK Takeover Code, the Nasdaq, FINRA or the SEC (or
their replacement bodies) or any rule or regulation promulgated thereby or thereunder. 

  

	9.4	Nothing in this Section 9 shall prevent disclosure of Confidential Information: 

 

	 	(a)	that was or becomes generally available to the public other than as a result of a disclosure by the receiving Party or its Representatives; 

 

	 	(b)	that was or becomes available to the receiving Party on a non-confidential basis from a source other than the Disclosing Party or its Representatives; provided
that such source was not known by the receiving Party to be bound by any agreement with the Disclosing Party to keep such information confidential; or 

  

	 	(c)	that has already been or is hereafter independently acquired or developed by the receiving Party or its Representatives without violating any confidentiality agreement
or other similar obligation. 

  

	10.	WAIVER AND AMENDMENT 

  

	10.1	Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by each
Party, or in the case of a waiver, by the Party against whom the waiver is to be effective. 

  

	10.2	 Any waiver of any term or condition of this Agreement shall not be construed as a waiver of any subsequent breach, or a subsequent waiver of the same
term or condition or a waiver of any other term or condition, of this Agreement. The failure of either Party to assert any of its rights hereunder shall not constitute a waiver of any of such rights. No failure or delay by either Party in exercising
any right, power or privilege under this Agreement shall operate as a waiver thereof nor shall any single or partial 

 

 13 

	 	 
exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. Other than as expressly set forth herein, the rights and remedies provided
in this Agreement shall be cumulative and not exclusive of any rights or remedies provided by Law. 

  

	11.	STANDSTILL 

  

	11.1	 For a period of five (5) years after the date hereof (the Standstill Period), Manchester shall not, and shall cause each of its
Subsidiaries not to, (i) directly or indirectly, acquire, seek to acquire or make an offer to acquire, alone or in concert with others, whether by purchase, gift, business combination or otherwise (a Transaction), any number of Equity
Securities such that, after giving effect to such Transaction, the Manchester Group (taken as a whole) would beneficially own, directly or indirectly, an aggregate number of Arsenal Shares representing (as a percentage) more than the lesser of
(A) the Coniston Closing Percentage or (B) (1) if the Emerald Closing does occur (but the Contingent Repurchase does not occur), 2% above the Emerald Closing Percentage or (2) if the Contingent Repurchase occurs, 2% above the
Contingent Repurchase Closing Percentage (the lesser of (A) or (B) is hereinafter referred to as the Maximum Arsenal Percentage), in each case unless such Transaction is approved by the Audit Committee of the Arsenal Board prior to
the consummation thereof, (ii) propose to enter into or seek to effect, directly or indirectly, alone or in concert with others, any merger, consolidation, recapitalization, reorganization or other business combination involving Arsenal or any
of its Subsidiaries or to purchase, directly or indirectly, alone or in concert with others, a material portion of the business or assets of Arsenal or any of its Subsidiaries, (iii) for so long as a Manchester Director is serving on the
Arsenal Board, initiate or propose any security holder proposal, (iv) make, or in any way participate, directly or indirectly, in any “solicitation” of “proxies” (as such terms are defined in Regulation 14A under the
Exchange Act) whether or not such solicitation is exempt under Rule 14a-2 under the Exchange Act, to vote or act by written consent, or seek to advise or influence any person with respect to the voting of, or the execution of a written consent in
respect of any Equity Securities of Arsenal or any of its Subsidiaries or become a “participant” in a “solicitation” of proxies (as such terms are defined in Regulation 14A under the Exchange Act), in each case with respect to
the election of directors to the Arsenal Board, or, for so long as a Manchester Director is serving on the Arsenal Board, with respect to any other matter, (v) deposit any Equity Securities into a voting trust or subject any such Equity
Securities to any arrangement or agreement with respect to the voting thereof by or together with any person other than Manchester, (vi) form, join, knowingly influence, participate in or knowingly encourage the formation of any 13D Group with
respect to any Equity Securities, (vii) except as specifically permitted by this Agreement, seek election to or seek to place a representative or other Affiliate or nominee on the Arsenal Board or seek the removal of any member of the Arsenal
Board other than for cause or in accordance with the recommendation of the Arsenal Nominating and Governance Committee or the Arsenal Board, (viii) for so long as a Manchester Director is serving on the Arsenal Board, initiate, propose or
knowingly take any public action in support of any security holder proposal to, or otherwise seek to have Arsenal amend its by-laws or its certificate of incorporation, (ix) other than in a public offering or a Rule 144 broker transaction,
sell, transfer or otherwise dispose of any Equity Securities to any Person or 13D Group who is prior to the consummation of such sale, transfer or other disposition known to Manchester to be a beneficial owner of 5% or more of the outstanding Equity
Securities (other than a beneficial owner who has filed or is eligible to file a Schedule 13G under the Exchange Act), (x) publicly disclose any intention, plan or arrangement inconsistent with the foregoing or (xi) publicly disclose a
willingness or desire to have any other Person engage in, any of the transactions or actions described in this Section 11.1. Manchester also agrees not to, and to cause each of its Subsidiaries during the Standstill Period not to,
request Arsenal or its Representatives, directly or indirectly, to amend or waive any provisions of this Section 11 (including this sentence), other than through a direct non-public communication by the CEO of

  

 14 

	 	 
Manchester to the CEO or non-executive Chairman of Arsenal (and to no other Person) that would not reasonably be expected to require any public disclosure on the part of Arsenal or Manchester and
that is not thereafter voluntarily disclosed by Manchester except as required by Law or any UK Regulatory Requirement. Nothing in this Section 11.1 shall limit Manchester’s power and right to purchase or acquire, directly or
indirectly, any Person (an Acquired Person) that at the time of such acquisition owns Arsenal Shares so long as such Arsenal Shares represent no more than 5% of the total assets of such Acquired Person at the time of such acquisition (an
Excepted Transaction); provided, that if Manchester completes an Excepted Transaction, it shall notify Arsenal promptly upon learning that an Acquired Person owns Arsenal Shares. If Manchester’s acquisition, directly or
indirectly, of Arsenal Shares pursuant to an Excepted Transaction would result in Manchester’s beneficial ownership being in excess of the Maximum Arsenal Percentage, then in such event the Maximum Arsenal Percentage shall be increased by a
percentage determined by dividing (x) only such number of Arsenal Shares purchased or acquired in connection with such Excepted Transaction that would result in Manchester beneficially owning an amount of Arsenal Shares in excess of the Maximum
Arsenal Percentage by (y) the number of then issued and outstanding Arsenal Shares, and such modified Maximum Arsenal Percentage shall remain in full force and effect; provided, however, that in the event Manchester or any of its
Subsidiaries, at any time after an Excepted Transaction, directly or indirectly, sells, transfers or otherwise disposes of any Arsenal Shares or such Acquired Person, then, in such event, the Maximum Arsenal Percentage shall be decreased by a
percentage determined by dividing (x) the amount of Arsenal Shares owned by such Acquired Person or sold, transferred or otherwise disposed of by Manchester or any of its Subsidiaries by (y) the number of then issued and outstanding
Arsenal Shares, and such modified Maximum Arsenal Percentage shall remain in full force and effect; provided, further, that in no event shall the Maximum Arsenal Percentage be decreased below the lesser of (A) the Coniston Closing
Percentage or (B) (1) if the Emerald Closing does occur (but the Contingent Repurchase does not occur), 2% above the Emerald Closing Percentage or (2) if the Contingent Repurchase occurs, 2% above the Contingent Repurchase Closing
Percentage, without giving effect, in the case of each of clauses (A) and (B), to any Excepted Transaction. 

  

	11.2	If any member of the Manchester Group inadvertently acquires any Equity Securities in violation of this Agreement, such member of the Manchester Group shall, as soon as
it becomes aware of such violation, (a) give immediate notice to Arsenal and (b) subject to Section 11.1(ix), immediately dispose of such Equity Securities to Persons who are not members of the Manchester Group or Affiliates of
any member thereof; provided that if the applicable member of the Manchester Group fails to comply with this Section 11.2 within ten (10) business days after becoming aware of such violation, Arsenal may also pursue any other
available remedy to which it may be entitled as a result of such violation. 

  

	11.3	In furtherance of the transactions contemplated hereby and by the Framework Agreement, Manchester covenants and agrees that neither Manchester nor any of its controlled
Affiliates will: 

  

	 	(a)	for a period of eighteen (18) months after the Coniston Closing, directly or indirectly (including by partnering with third parties) deploy, sell, license or
market any electronic medical health record or physician practice management software, related applications or solutions (the Restricted Activities), in any country in the world where Arsenal is conducting Restricted Activities on the date
hereof; provided, however, that the reference to “related applications or solutions” in the definition of Restricted Activities shall not preclude MOSS from conducting its business as conducted on the date of the Framework
Agreement or reasonable extensions thereof in the healthcare information exchange market which, for the avoidance of doubt, will in no event include electronic medical health record or physician practice management software; or

  

 15 

	 	(b)	for a period of eighteen (18) months after the Coniston Closing, utilize the name “Misys” or any trade name, trademark, brand name, domain name or logo
containing or associated with the name “Misys” (collectively, the Manchester Marks) in connection with any healthcare information technology solutions, or grant to any third party the right or license to use the Manchester Marks in
connection with any healthcare information technology solutions anywhere in the world. 

  

	11.4	Notwithstanding anything contained in Section 11.3(b) to the contrary, Misys Open Source Solutions, LLC (MOSS) shall be permitted to utilize the MOSS
name or any trade name, trademark, brand name, domain name or logo relating to MOSS in connection with healthcare information technology solutions other than in connection with any of the Restricted Activities. 

 

	12.	TERMINATION 

 This
Agreement shall only be terminated with the prior written consent of both Arsenal and Manchester. 
  

	13.	GENERAL 

  

	13.1	The provisions of this Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns; provided
that neither Party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other Party. Any attempted assignment in violation of this Section 13.1 shall be void.

  

	13.2	This Agreement constitutes the entire agreement and understanding between the Parties with respect to the subject matter of this Agreement and supersedes all prior
agreements and understandings, both oral and written, between Manchester and Arsenal with respect to the subject matter hereof, including the Original Relationship Agreement. All terms and provisions of the Original Relationship Agreement are hereby
terminated and are null and void and of no further force and effect. 

  

	13.3	This Agreement may be signed in any number of counterparts (including by fax or other electronic signature), each of which shall be an original, with the same effect as
if the signatures were upon the same instrument. This Agreement shall become effective when each Party shall have received a counterpart of this Agreement signed by the other Party. This Agreement is for the sole benefit of the Parties and their
successors and permitted assigns and nothing express or implied in this Agreement is intended or shall be construed to confer upon any Person other than the Parties any legal or equitable rights or remedies under this Agreement.

  

	13.4	If any provision of this Agreement (or any portion thereof) or the application of any such provision (or any portion thereof) to any Person or circumstance shall be
held invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision of this Agreement (or the remaining portion thereof) or the application
of such provision to any other Person or circumstances. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect
the original intent of the Parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby are completed as originally contemplated to the greatest extent possible. 

 

	13.5	Nothing contained herein shall limit in any way Manchester’s rights under the Registration Rights Agreement (as defined in the Framework Agreement).

  

 16 

	13.6	If Arsenal (i) reduces the number of Arsenal Shares outstanding and increases the share price proportionately by a reverse stock split or any similar action or
(ii) increases the number of Arsenal Shares outstanding by a stock dividend, subdivision or split-up of Arsenal Shares or any similar action, in each case, the number of Arsenal Shares set out in Section 3.1(i) shall be adjusted
proportionately following the record date for such transaction. 

  

	14.	NOTICES 

 All notices,
requests, claims, demands and other communications required or permitted to be given under this Agreement shall be in writing and shall be delivered by hand, sent by fax or sent by international overnight courier service and shall be deemed given
when so delivered by hand or fax (if received prior to 5 p.m. in the place of receipt and such day is a business day in the place of receipt; otherwise, any such notice, request or communication shall be deemed not to have been received until the
next succeeding business day in the place of receipt), or one (1) business day after mailing in the case of international overnight courier service, to the respective Parties at the following addresses (or at such other address for a Party as
shall be specified in a notice given in accordance with this Section 14): 
 if to Manchester, to: 

 

			
	Misys plc
	One Kingdom Street
	Paddington
	London W2 6BL, UK
	Telephone:	    	+44 (0)20 3320 5000
	Fax:	    	+44 (0)20 3320 1771
	Attention:	    	General Counsel

with a copy to: 
  

			
	Allen & Overy LLP
	1221 Avenue of the Americas
	New York, NY 10020
	Telephone:	    	+1 212 610 6471
	Fax:	    	+1 212 610 6399
	Attention:	    	A. Peter Harwich

if to Arsenal, to: 
  

			
	Allscripts-Misys Healthcare Solutions, Inc.
	222 Merchandise Mart Plaza, Suite 2024
	Chicago, IL 60654
	Telephone:	    	+1 800 654 0889
	Fax:	    	+1 312 506 1208
	Attention:	    	General Counsel

with a copy to: 
  

			
	Sidley Austin LLP
	One South Dearborn
	Chicago, IL 60603
	Telephone:	    	+1 312 853 7000
	Fax:	    	+1 312 853 7036
	Attention:	    	Frederick C. Lowinger; Gary D. Gerstman

  

 17 

			
	and
	
	Winston & Strawn LLP
	35 W. Wacker Drive
	Chicago, IL 60601
	Telephone:	    	+1 312 558 5600
	Fax:	    	+1 312 558 5700
	Attention:	    	Robert F. Wall

  

	15.	GOVERNING LAW 

 This
Agreement (and any claims or disputes arising out of or related to this Agreement or to the inducement of any Party to enter into this Agreement, whether for breach of contract, tortious conduct or otherwise and whether predicated on common law,
statute or otherwise) shall in all respects be governed by and construed in accordance with the Laws of the State of Delaware, including all matters of construction, validity and performance, in each case without reference to any conflict of law
rules that might lead to the application of the Laws of any other jurisdiction. 
  

	16.	ENFORCEMENT 

  

	16.1	The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific
terms or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to seek an injunction or injunctions or other appropriate equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and
provisions of this Agreement in the Delaware Court of Chancery (unless such court shall lack subject matter jurisdiction over such action, in which case, in any state or federal court located in Delaware), this being in addition to any other remedy
to which they are entitled at law or in equity, and the Parties hereby waive in any such proceeding the defense of adequacy of a remedy at law and any requirement for the securing or posting of any bond or any other security related to such
equitable relief. 

  

	16.2	Each Party irrevocably and unconditionally submits to the exclusive jurisdiction of the Delaware Court of Chancery, or if such court is unavailable, state or federal
courts located in Delaware, for the purposes of any suit, action or other proceeding arising out of this Agreement or the transactions contemplated hereby. Each Party hereby agrees that it will not bring any action relating to this Agreement or the
transactions contemplated hereby in any court other than the Delaware Court of Chancery (unless such court shall lack subject matter jurisdiction over such action, in which case, in any state or federal court located in Delaware). Each Party hereby
waives formal service of process and agrees that service of any process, summons, notice or document by U.S. registered mail to such Party’s respective address set forth above shall be effective service of process for any action, suit or
proceeding in Delaware with respect to any matters to which it has submitted to jurisdiction in this Section 16.2. Each Party irrevocably and unconditionally waives any objection to the laying of venue of any action, suit or proceeding
arising out of this Agreement or the transactions contemplated hereby in such courts and hereby and thereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or proceeding
brought in any such court has been brought in an inconvenient forum. 

  

 18 

	16.3	EACH PARTY HEREBY EXPRESSLY AND IRREVOCABLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY ACTION,
PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) DIRECTLY OR INDIRECTLY RELATING TO ANY DISPUTE ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. Each Party
(a) certifies that no representative, agent or attorney of the other Party has represented, expressly or otherwise, that such other Party would not, in the event of litigation, seek to enforce the foregoing waiver and (b) acknowledges that
it and the other Party have been induced to enter into this Agreement by, among other things, the mutual waivers and certifications in this Section 16.3. 

[SIGNATURE PAGE FOLLOWS] 
  

 19 

 SIGNATORIES 

IN WITNESS WHEREOF, Manchester and Arsenal have caused their respective duly authorized officers to execute this Agreement as of the day and year
first above written. 
  

			
	MISYS PLC
		
	By:	 	 /s/ J. Michael Lawrie

	Name:	 	J. Michael Lawrie
	Title:	 	Chief Executive Officer
	
	ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC.
		
	By:	 	 /s/ Glen Tullman

	Name:	 	Glen Tullman
	Title:	 	Chief Executive Officer

  

 20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}]]